The ingredient is made using a patented fungal fermentation process.
Photo © iStockphoto.com/jasminam
New clinical results show that Ultimine, a whole-food iron ingredient derived from the fermentation of koji (Aspergilus oryzae), releases slowly in the body for optimal bioavailability. By contrast, says supplier Naturex (South Hackensack, NJ), “most iron supplements in the market are absorbed quickly, potentially leading to iron overload.” The company will share more of these clinical results at this week’s SupplySide West trade show.
Ultimine was developed by Naturex and Cura Global Health Inc. (Aimes, IA). The companies use a patented fungal fermentation process to obtain Ultimine iron from koji. “Ultimine iron is the first generation of products within a proprietary koji fermentation platform that aims to develop whole-food nutrients with better efficacy,” said Naturex in a press release. “The second generation of products, Ultimine Multi 7, is already available on the U.S. market and provides 25% of the RDI for seven nutrients, within a small dosage.”
Learn more about these clinical results at SupplySide Booth #5157. At the show, Naturex will also highlight its heart health ingredients Aronox (aronia extract, beneficial for healthy blood pressure and cholesterol) and Sweoat (oat beta-glucan, beneficial for reducing cholesterol levels).
New study shows that vitamin K2 as MK-7 may have neuroprotective qualities
May 17th 2024Researchers examined the effects of MK-7 and menaquinone-4 (MK-4) on neuroblastoma cells to understand how different forms of vitamin K2 impact the expression of genes involved in neurodegeneration and neuroinflammation.
Judge in CRN’s complaint against NY denies the State’s motion to dismiss
May 14th 2024New York State's motion to dismiss CRN's lawsuit against the law banning the sale of weight management and muscle-building supplements to minors has been partially denied, allowing CRN to proceed with its First Amendment Claim.
New study shows that vitamin K2 as MK-7 may have neuroprotective qualities
May 17th 2024Researchers examined the effects of MK-7 and menaquinone-4 (MK-4) on neuroblastoma cells to understand how different forms of vitamin K2 impact the expression of genes involved in neurodegeneration and neuroinflammation.
Judge in CRN’s complaint against NY denies the State’s motion to dismiss
May 14th 2024New York State's motion to dismiss CRN's lawsuit against the law banning the sale of weight management and muscle-building supplements to minors has been partially denied, allowing CRN to proceed with its First Amendment Claim.
2 Commerce Drive
Cranbury, NJ 08512